Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 2
2020 2
2021 1
2022 2
2023 4
2025 4
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Lysosomal NKG7 restrains mTORC1 activity to promote CD8+ T cell durability and tumor control.
Ham H, Hirdler JB, Bihnam DT, Mao Z, Gicobi JK, Macedo BG, Rodriguez-Quevedo MF, Schultz DF, Correia C, Zhong J, Martinez KE, Banuelos A, Ashton DS, Lagnado AB, Guo R, Pessoa R, Pandey A, Li H, Lucien F, Borges da Silva H, Dong H, Billadeau DD. Ham H, et al. Among authors: gicobi jk. Nat Commun. 2025 Feb 14;16(1):1628. doi: 10.1038/s41467-025-56931-6. Nat Commun. 2025. PMID: 39952956 Free PMC article.
Plasma exchange and radiation resensitize immunotherapy-refractory melanoma: a phase I trial.
Orme JJ, Zhang H, Lingamaneni P, Kim Y, Lavoie R, Dorr M, Dizona P, Hirdler J, Bering EA, Gicobi JK, Hsu M, Dale H, Childs DS, Kottschade LA, McWilliams RR, Block MS, Mansfield AS, Markovic SN, Olivier K, Owen D, Lester S, Ma D, Dronca RS, Dong H, Lucien F, Packard AT, Winters JL, Park SS. Orme JJ, et al. Among authors: gicobi jk. Nat Commun. 2025 Mar 13;16(1):2507. doi: 10.1038/s41467-025-57865-9. Nat Commun. 2025. PMID: 40082438 Free PMC article. Clinical Trial.
Immune resilience in response to cancer therapy.
Gicobi JK, Barham W, Dong H. Gicobi JK, et al. Cancer Immunol Immunother. 2020 Nov;69(11):2165-2167. doi: 10.1007/s00262-020-02731-4. Cancer Immunol Immunother. 2020. PMID: 33011909 Free PMC article. No abstract available.
PD-1 prelimits both the cytotoxic and exhaustion potential in thymic CD8+ T cells and impacts the maintenance of peripheral tumor immunity.
Mao Z, Hirdler JB, Gicobi JK, Maynes M, Hsu MA, Dellacecca ER, Zhang W, Teske JJ, Li Y, Zhao G, Lucien-Matteoni F, da Silva HB, Billadeau DD, Dong H. Mao Z, et al. Among authors: gicobi jk. bioRxiv [Preprint]. 2025 Jan 18:2025.01.18.631253. doi: 10.1101/2025.01.18.631253. bioRxiv. 2025. PMID: 39868106 Free PMC article. Preprint.
NKG7 Is a T-cell-Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy.
Wen T, Barham W, Li Y, Zhang H, Gicobi JK, Hirdler JB, Liu X, Ham H, Peterson Martinez KE, Lucien F, Lavoie RR, Li H, Correia C, Monie DD, An Z, Harrington SM, Wu X, Guo R, Dronca RS, Mansfield AS, Yan Y, Markovic SN, Park SS, Sun J, Qin H, Liu MC, Vasmatzis G, Billadeau DD, Dong H. Wen T, et al. Among authors: gicobi jk. Cancer Immunol Res. 2022 Feb;10(2):162-181. doi: 10.1158/2326-6066.CIR-21-0539. Epub 2021 Dec 15. Cancer Immunol Res. 2022. PMID: 34911739 Free PMC article.
A Novel PD-L1 Antibody Promotes Antitumor Function of Peripheral Cytotoxic Lymphocytes after Radical Nephrectomy in Patients with Renal Cell Carcinoma.
An Z, Hsu MA, Gicobi JK, Xu T, Harrington SM, Zhang H, Pavelko KD, Hirdler JB, Lohse CM, Nabavizadeh R, Pessoa RR, Sharma V, Thompson RH, Leibovich BC, Dong H, Lucien F. An Z, et al. Among authors: gicobi jk. J Immunol. 2023 Jun 15;210(12):2029-2037. doi: 10.4049/jimmunol.2200933. J Immunol. 2023. PMID: 37163328 Free PMC article.
13 results